Skip Navigation
Skip to contents

PHRP : Osong Public Health and Research Perspectives

OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
2 "Comorbidity"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Original Articles
Quality of life in patients treated for COVID-19–associated mucormycosis at a tertiary care hospital
Pragya Kumar, Rajath Rao UR, Nilanjan Roy, Deepika Agrawal, Shamshad Ahmad, Kranti Bhavana
Osong Public Health Res Perspect. 2023;14(2):119-128.   Published online April 18, 2023
DOI: https://doi.org/10.24171/j.phrp.2022.0307
  • 1,834 View
  • 55 Download
Graphical AbstractGraphical Abstract AbstractAbstract PDF
Objectives
Coronavirus disease 2019 (COVID-19)–associated mucormycosis (CAM) has emerged as a formidable infection in patients with COVID-19. The aggressive management of CAM affects quality of life (QOL); thus, this study was designed to assess the QOL in patients with CAM at a tertiary healthcare institution.
Methods
This cross-sectional study of 57 patients with CAM was conducted over 6 months using a semi-structured standard questionnaire (the abbreviated World Health Organization Quality of Life questionnaire [WHO-BREF]) and a self-rated improvement (SRI) scale ranging from 0 to 9. Cut-off values of ≤52 and <7 were considered to indicate poor QOL and poor improvement, respectively. The correlations of QOL and SRI scores were evaluated using Spearman rho values.
Results
In total, 27 patients (47.4%; 95% confidence interval [CI], 34.9%–60.1%) and 26 patients (45.6%; 95% CI, 33.4%–58.4%) had poor QOL and poor SRI scores, respectively. The overall median (interquartile range) QOL score was 52 (41–63). Headache (adjusted B, −12.3), localized facial puffiness (adjusted B , −16.4), facial discoloration (adjusted B, −23.4), loosening of teeth (adjusted B, −18.7), and facial palsy (adjusted B, −38.5) wer e significantly associated with the QOL score in patients with CAM.
Conclusion
Approximately 1 in 2 patients with CAM had poor QOL and poor improvement. Various CAM symptoms were associated with QOL in these patients. Early recognition is the key to optimal treatment, improved outcomes, and improved QOL in patients with CAM.
Health-Related Quality of Life Based on Comorbidities Among Patients with End-Stage Renal Disease
Jieun Cha, Dallong Han
Osong Public Health Res Perspect. 2020;11(4):194-200.   Published online August 31, 2020
DOI: https://doi.org/10.24171/j.phrp.2020.11.4.08
  • 6,275 View
  • 135 Download
  • 10 Web of Science
  • 15 Crossref
AbstractAbstract PDF
Objectives

The aim of this study was to investigate comorbidities in patients with end-stage renal disease, and to compare health-related quality of life (HRQOL) according to the type, and number of comorbidities.

Methods

A total of 250 adults undergoing hemodialysis were recruited at local clinics. HRQOL was measured using the 12-item Medical Outcomes Study Short Form questionnaire. Data were analyzed using descriptive statistics, analysis of variance, and t test.

Results

Around 70.8% of patients with end stage renal disease had 1 or more comorbidities, and the most common comorbidities were hypertension, diabetes, and cardiovascular disease. HRQOL was significantly different based on the number of comorbidities (F = 9.83, p < 0.001). The effect of comorbidities on the scores for mental health domains of the HRQOL questionnaire was not conclusive compared with the scores for the physical domain which were conclusive. Among the comorbidities, diabetes was associated with a lower quality of life.

Conclusion

The customized management of diabetic and hypertensive patients is necessary for the early detection and prevention of chronic kidney disease, and slowing the progression of renal disease and managing cardiovascular risk factors is essential.

Citations

Citations to this article as recorded by  
  • Quality of Life in End-Stage Renal Disease Patients Undergoing Hemodialysis and Its Affecting Factors in a Hemodialysis Unit of General Hospital Denpasar
    Agustina Nila Yuliawati, Pande Made Desy Ratnasari, Ni Luh Putu Satria Maharani
    Borneo Journal of Pharmacy.2023; 6(3): 320.     CrossRef
  • The Effect of Chronic Kidney Disease or End-stage Kidney Disease on Perioperative Outcomes and Healthcare Utilization in Patients Undergoing Bariatric Surgery
    Yung Lee, Léa Tessier, Audrey Jong, Adelia Padoan, Yasith Samarasinghe, Tyler McKechnie, Amber O. Molnar, Michael Walsh, Aristithes Doumouras, Jerry Dang, Matthew Kroh, Dennis Hong
    Obesity Surgery.2023; 33(5): 1476.     CrossRef
  • Navigating through the haemostatic paradox in kidney failure: A practical overview
    Jessica Caruana, Nicoletta Riva, Kevin Vella, Andrew Davenport, Alexander Gatt
    British Journal of Haematology.2023; 202(2): 230.     CrossRef
  • IgA nephropathy in adults with epidermolysis bullosa
    Manrup K Hunjan, Ajoy Bardhan, Natasha Harper, Dario Leonardo Balacco, Gerald Langman, Vijay Suresh, Adrian Heagerty
    Clinical and Experimental Dermatology.2023; 48(8): 920.     CrossRef
  • Comorbid Conditions in Kidney Transplantation: Outcome Analysis at King Abdulaziz Medical City
    Abdulrahman R Al Tamimi, Bader A Aljaafri, Fahad Alhamad, Sultan Alhoshan, Awatif Rashidi, Basayel Dawsari, Ziad A Aljaafri
    Cureus.2023;[Epub]     CrossRef
  • Duration of Hemodialysis and its Impact on Quality of Life
    Bushra Akram, Hafiz Shafique Ahmad, Muhammad Tahsin Akhtar, Ahmad Bilal, Khizra Iqbal
    Pakistan Journal of Health Sciences.2023; : 31.     CrossRef
  • Association between heart failure and arteriovenous access patency in patients with end-stage renal disease on hemodialysis
    Andrea T. Fisher, Bianca Mulaney-Topkar, Brian M. Sheehan, Manuel Garcia-Toca, Ehab Sorial, Michael D. Sgroi
    Journal of Vascular Surgery.2023;[Epub]     CrossRef
  • Health Literacy and Change in Health-Related Quality of Life in Dialysed Patients
    Ivana Skoumalova, Andrea Madarasova Geckova, Jaroslav Rosenberger, Maria Majernikova, Peter Kolarcik, Daniel Klein, Andrea F. de Winter, Jitse P. van Dijk, Sijmen A. Reijneveld
    International Journal of Environmental Research an.2022; 19(2): 620.     CrossRef
  • Physical Activity and Health-Related Quality of Life of Patients on Hemodialysis with Comorbidities: A Cross-Sectional Study
    Yu-Hui Wu, Yu-Juei Hsu, Wen-Chii Tzeng
    International Journal of Environmental Research an.2022; 19(2): 811.     CrossRef
  • Disease Knowledge, Self-Efficacy, and Quality of Life in Patient With Hypertensive Nephropathy
    Yen-Yen Chen, Mei-Chen Lee, Shu-Fang Vivienne Wu, Yueh-Min Liu, Hui-Mei Chen
    Clinical Nursing Research.2022; 31(6): 1179.     CrossRef
  • The mediating effect of self‐efficacy in the relationship between mental health and quality of life in patients with hypertensive nephrology
    Mei‐Chen Lee, Yen‐Yen Chen, Chun‐Yi Tai, Shu‐Fang Vivienne Wu
    Journal of Advanced Nursing.2022; 78(9): 2827.     CrossRef
  • The relationship between grip strength with health-related quality of life and mortality in hemodialysis patients
    Clara S. A. Sugizaki, Hellen C. N. Rodrigues, Jéssica F. M. Ivo, Ana T. V. S. Freitas, Maria L. F. Stringhini, Sérgio A. R. Paiva, Marcos F. Minicucci, Maria R. G. Peixoto, Nara A. Costa
    Nutrire.2022;[Epub]     CrossRef
  • Factors Affecting Quality of Life in Hemodialysis Patients
    Ade Yonata, Nurul Islamy, Achmad Taruna, Lukman Pura
    International Journal of General Medicine.2022; Volume 15: 7173.     CrossRef
  • Health related quality of life of patients undergoing in-centre hemodialysis in Rwanda: a cross sectional study
    Gloria Shumbusho, Celestin Hategeka, Marianne Vidler, Jules Kabahizi, Marla McKnight
    BMC Nephrology.2022;[Epub]     CrossRef
  • The Short Form-6 Dimension (SF-6D) Validity and Reliability in Hemodialysis Patients
    Anisa Zulfa Fatihah, Tri Murti Andayani, Nanang Munif Yasin
    JURNAL FARMASI DAN ILMU KEFARMASIAN INDONESIA.2021; 8(2): 150.     CrossRef

PHRP : Osong Public Health and Research Perspectives